Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon
Venous thromboembolism (VTE) carries a long-term risk of recurrence. Anticoagulation is
administered with the aim of both treating the index VTE (initial management [first 5-21 days
of diagnosis] and primary treatment [until 3-6 months]), and preventing recurrences
(secondary prevention [beyond 3-6 months])[1]. Intensity and duration of anticoagulant
therapy should therefore be calibrated to the individual risk profile, extending treatment until
recurrence risk outweighs the risk for anticoagulant-related bleeding. The presence of …
administered with the aim of both treating the index VTE (initial management [first 5-21 days
of diagnosis] and primary treatment [until 3-6 months]), and preventing recurrences
(secondary prevention [beyond 3-6 months])[1]. Intensity and duration of anticoagulant
therapy should therefore be calibrated to the individual risk profile, extending treatment until
recurrence risk outweighs the risk for anticoagulant-related bleeding. The presence of …
以上显示的是最相近的搜索结果。 查看全部搜索结果